Table 2 Clinical and laboratory characteristics of patients at long-term evaluation (N = 72)

Age at evaluation / follow-up duration (years)

6.82 ± 2.93 (range: 2.28–12.02)

 2—< 6 years, n (%)

30 (41.6)

 6—13 years, n (%)

42 (58.4)

Height-SDS

-0.14 ± 1.17

 Short stature, n (%)

2 (2.8)

Weight-SDS

-0.02 ± 1.31

 Malnutrition, n (%)

4 (5.6)

 Overweight^a, n (%)

9 (12.5)

 Obesity^a, n (%)

10 (13.8)

Laboratory findings

Blood

 Hemoglobin (g/dl)

12.97 ± 0.81

 Anemia, n (%)

4 (5.6)

 BUN (mg/dl)

12.64 ± 2.74

 Creatinine (mg/dl)

0.44 ± 0.11

 Uric acid (mg/dl)

3.78 ± 0.91

 Sodium (mEq/L)

141.6 ± 1.9

 Potassium (mEq/L)

4.52 ± 0.36

 Chloride (mEq/L)

105.8 ± 2.0

 Calcium (mg/dl)

9.68 ± 0.44

 Phosphorus (mg/dl)

4.86 ± 0.68

 Magnesium (mg/dl)

2.07 ± 0.17

 Serum bicarbonate (mmol/L)

22.6 ± 1.2

eGFR (ml/min/1.73m²)

152.3 ± 26.6

 > 187 ml/min/1.73m², n (%)

7 (9.7)

 > 150 ml/min/1.73m², n (%)

37 (51.3)

Median ACR (mg/g)

17.5 (IQR 17.3, range: 2.75 – 199.85)

 0–30, n/N (%)

62/71 (87.3)

 > 30, n/N (%)

9/71 (12.7)

Urinary

 TPR (%)

90.3 ± 3.6

 TPR < 85%, n/N (%)

5/70 (7.1)

 TmP/GFR (mg/dl)

4.39 ± 0.66

 TmP/GFR > 6 mg/dl, n (%)

1/70 (1.4)